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Abstract 
Background: Chronic migraine is a disabling condition that impacts multiple aspects of migraineurs’ lives. Although 
pharmacological treatments can help to treat the pain associated with migraine headache, chronic migraineurs often 
experience side-effects of pharmacological treatments. Those experiences may contribute to the observed growth in 
complementary and alternative medicine (CAM) use among migraineurs. Relatively little is known about the patterns 
of CAM treatment and the characteristics of chronic migraineurs. Therefore, the purpose of the present study is to 
investigate the characteristics of chronic migraineurs who use CAM treatment and the relationship among satisfac-
tion with current CAM use, negative life impact, migraine outcomes, and psychiatric comorbidities among chronic 
migraineurs.
Methods: 2907 participants were recruited from a well-known online migraine headache resource. All participants 
were US adults aged 18 years or older. Migraineurs are referred to this website through various routes (e.g., referral 
from healthcare providers, internet search, obtaining information from research papers, personal invitation from other 
users, and information shared on social media etc.). Participants completed a 30-min self-report-survey in the spring 
of 2014.
Results: Almost half of the participants reported that they are currently using more than three different CAM treat-
ments even though the majority of the participants reported neutral or dissatisfied with their current CAM treatment. 
Chronic migraineurs who use CAM treatments were more likely to experience prolonged or frequent migraine head-
aches (p = .018, η2 = .0021), and experience greater negative life impact from their headaches (p = .000, η2 = .0172) 
compared to non-CAM users. CAM treatment satisfaction was inversely related to the number of psychiatric comor-
bidities, frequency of migraines, and number of migraine symptoms (p’s < .05). However, CAM treatment satisfaction 
was more strongly correlated with migraine outcomes than psychiatric comorbidities.
Conclusions: Chronic migraineurs often pursue multiple CAM treatments in spite of low levels of satisfaction with 
those treatments. Patients who experience relief from traditional treatments are less likely to seek the out additional 
CAM treatments. Thus it is often the sicker migraine patients who use CAM. More attention is needed to consider 
migraine treatment resistance, and psychological factors in planning the treatment of chronic migraineurs as those 
factors may play an important role in treatment choices by patients.
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life impact
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Background
Migraine headaches are a common health condition 
which affects more than 10 % of the global adult popula-
tion (Adams et al. 2013). In the US, 14.2 % of US adults 
were affected by migraine or severe headaches (Burch 
et al. 2015). Migraine is a disabling condition that impacts 
not only productivity and attendance at work or school, 
but also quality of life at home.
Pharmacological treatments of migraine headaches can 
help to relieve the pain and symptoms associated with 
migraine headache. However, migraineurs often experi-
ence side-effects of pharmacological treatments and fre-
quent use of medications can lead to medication overuse 
headaches (Adams et al. 2013). The limits to pharmaco-
logical treatments may explain high usage of complemen-
tary and alternative medicine (CAM) among migraineurs 
(Wells et al. 2011). The number of migraineurs who are 
using CAM treatment in conjunction with traditional 
medical treatments has been growing over the years 
(Eisenberg et  al. 1998; Jacobson et  al. 2009; Kaptchuck 
and Eisenberg 1998). Consistent with this pattern, a 
number of studies investigating the prevalence and pat-
terns of CAM treatment in migraineurs have been slowly 
growing, however, previous studies were conducted 
within individual headache clinics with limited popula-
tions (Adams et al. 2013; Wells et al. 2011).
Relatively little is known about the patterns of CAM 
treatment and the characteristics of migraineurs in the 
general community; therefore, the current study focuses 
on migraineurs who are recruited nationwide from 
across the US. Due to technological advancement and 
widespread internet access in recent years, most people 
search for health-related information on the internet and 
also seek emotional and instrumental support from the 
internet community. Considering this trend, the present 
study analyzed the data collected from a community-
based website for migraine headache in the US.
Previous study (Wachholtz et  al. 2015) found that 
chronic migraineurs often experienced high levels of 
dissatisfaction with medical and CAM treatments for 
migraine headaches. This study further indicated that 
chronic migraineurs tended to seek multiple treatments 
instead of focusing on a single treatment. This tendency 
may occur because migraineurs use CAM treatments 
not only to treat their migraine symptoms but also to 
improve the quality of life by preventing headaches or by 
increasing their energy levels (Wells et al. 2011). Previous 
studies (Lipton et al. 2003; Malone et al. 2015; Smither-
man et  al. 2011; Wachholtz et  al. 2015) indicated that 
migraine headache was associated with negative impacts 
in different domains of life (e.g., physical function, social 
function, role function, mental health). However, rela-
tively little is known about the relationship between 
satisfaction with CAM use and the negative life impacts 
of migraine among migraineurs.
In order to address gaps in previous studies mentioned 
above, the present study investigated the data collected 
on the web-community in order to provide insights into 
(1) the characteristics of chronic migraine sufferers, (2) 
chronic migraineurs who use CAM treatment compared 
to who do not use CAM treatment; (3) the prevalence of 
different types of CAM use; and (4) the details of negative 
life impact affected by migraine; and (5) the relationship 
among satisfaction with current CAM use, negative life 
impact, migraine outcomes, and psychiatric comorbidi-
ties among chronic migraineurs.
Methods
Participants
2907 participants were recruited from a well-known 
online migraine headache resource (Migraine in Amer-
ica, website: https://migraine.com/). All participants were 
US adults aged 18  years or older have been diagnosed 
with chronic migraine by their physicians who are diag-
nosed chronic migraine using ICD-9 criteria. However, 
197 participants did not complete the survey or did not 
meet criteria of being diagnosed with chronic migraine; 
these individuals were excluded in the analysis of the 
present study. Among 2710 completing participants, the 
majority of participants were female (92.8  %; shown in 
Table  1). More than half of the participants were older 
than 40 years old. Most of the participants (75 %) experi-
enced their first migraine symptoms more than 10 years 
ago and 25  % of the respondents reported experiencing 
migraine symptoms lasting more than 4  h at least 20 
times per month. Regarding symptoms associated with 
migraine, head pain and sensitivity to light were most 
common, followed by sensitivity to sound, difficulty con-
centrating, nausea, and mood change (Table 1). The most 
common comorbid disorders associated with migraine 
were depression and anxiety, followed by chronic pain, 
irritable bowel syndrome, and chronic fatigue. Almost 
70  % of the participants experienced at least one psy-
chiatric comorbiditity. The most commonly reported 
triggers to migraine headaches were stress and envi-
ronmental triggers, followed by lack of sleep (Table  2). 
Almost 70 % of the respondents reported taking special 
steps to avoid triggers while only 34 % of the participants 
reported keeping a journal to track their migraine epi-
sodes. Lastly, more than half of the participants either 
avoided or stopped migraine medications due to side 
effects (Table 2).
Procedures
All methods were approved by the University of Massa-
chusetts IRB and all participants indicated their consent 
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to participate in the study prior to answering any of the 
study questions. Migraineurs are referred to this web-
site through various routes (e.g., referral from healthcare 
providers, internet search, obtaining information from 
research papers, personal invitation from other users, 
and information shared on social media etc.). IP address 
logging prevented participants from responding to the 
survey multiple times. Participants were not compen-
sated in any way for their participation in the survey. Par-
ticipants completed a 30-min self-report-survey in the 
spring of 2014.
Materials
The survey included questions regarding demograph-
ics, migraine symptoms and diagnosis, general impact of 
migraine, and medications and treatments of migraine 
headache. A subset of questions was selected for analy-
sis in the present study: demographics (e.g., gender, age), 
questions related to migraine onset, frequency of head-
ache symptoms, comorbid disorders, triggers to migraine, 
and headache treatments (both conventional and CAM). 
Participants indicated which CAM therapies they were 
currently using or had historically used from an exten-
sive list. The present study used CAM definition adopted 
by Cochrane Collaboration, which defined CAM as “all 
practices and ideas self-defined by their users as pre-
venting or treating illness or promoting health and well-
being” (Zollman and Vickers 1999, p. 693). Total scores 
for current CAM treatments were created by adding the 
numbers of therapies each participant selected. For those 
who selected “other” participants were asked to specify 




 Female 2514 92.8
 Male 196 7.2
Age in years
 <18 0 0
 18–24 189 7
 25–39 914 33.7
 40–54 1294 47.7
 >55 313 11.5
First migraine symptoms
 <1 year 38 1.4
 1–5 years 267 9.9
 6–10 years 348 12.8
 10+ years 2057 75.9
Migraine symptoms frequency lasting 4+ 
hours per month
 1–4 times 464 17.1
 5–9 times 564 20.8
 10–14 times 513 18.9
 15–19 times 488 18
 20+ times 681 25.1
Symptoms associated with migraine head-
ache
 Head pain 2552 94.2
 Sensitivity to light 2374 87.6
 Nausea and/or vomiting 2047 75.5
 Diarrhea, constipation 786 29
 Difficulty concentrating 2090 77.1
 Fatigue 1941 71.6
 Neck pain 1877 69.3
 Dizziness/lightheadedness 1588 58.6
 Sensitivity to sound 2172 80.1
 Visual changes 1391 51.3
 Weakness 1190 43.9
 Mood change 1601 59.1
 Sensitivity to smell 1650 60.9
 Numbness/tingling 908 33.5
 Vertigo 761 28.1
 Puffy eyelid 608 22.4
 Food cravings 542 20
 Other 381 14.1




 Stress 1557 57.5
 Environmental (weather etc.) 1589 58.6
 Lack of sleep 1382 51
 Hormones/menstrual cycle 1179 43.5
 Certain food or drinks 1254 46.3
 Missing meals 1096 40.4
 Certain smells 1058 39
 Alcohol/drugs 709 26.2
 Physical activity 603 22.3
 Sexual activity 165 6.1
 Other 392 14.5
 Any special steps to avoid these triggers 1793 66.2
 Currently keep a journal to track migraine episodes 937 34.6
 Avoided using a medicine due to side effects 1689 62.3
 Stopped using a medicine due to side effects 1709 63.1
Side effects
 Nausea/vomiting 613 22.6
 Stomach ache 363 13.4
 Rebound headaches 898 33.1
 Dizziness 594 21.9
 Other 1237 45.6
Page 4 of 10Lee et al. SpringerPlus  (2016) 5:1006 
the type of therapies they are currently using and each 
response was assigned into different categories of current 
CAM use (i.e., bodywork, mental well-being, Eastern-
based practices, nutritional therapy, and others). Satisfac-
tion with current pharmacological treatments and CAM 
treatments was assessed by one question: “how satisfied 
are you with your current therapies for migraine?” Partic-
ipants were asked to rate how much they are satisfied on 
5-point Likert scale ranging from extremely dissatisfied 
(coded as 0) to extremely satisfied (coded as 4) for each 
category of CAM (Table 3). The same scale was applied 
to satisfaction with pharmacological treatments.
Negative life impact was measured by 6 statements 
(1) Migraines affect my ability to maintain relationships; 
(2) Migraines have impacted my professional achieve-
ment; (3) I have lost a job due to my migraines; (4) I’ve 
lost friends due to my migraines; (5) Migraines contrib-
uted to my divorce/separation; and (6) Migraines impact 
my relationship with my child/children). Total score for 
negative life impact was a summation of the negative life 
items endorsed.
Data analysis
Descriptive statistics, analysis of variance, and Pearson’s 
R correlation analyses were used to describe participant’s 
demographic information and migraine characteristics 
and examine relationships among different variables in 
the survey data. Path analyses were performed to inves-
tigate differential relationships among satisfaction with 
CAM treatment and pharmacological treatment, number 
of psychiatric co-morbid disorders, migraine frequency, 
number of migraine symptoms, and negative life impact. 
In order to explore the discrepancies in the characteris-
tics of CAM users and non-CAM users, two CAM use 
groups were created; participants who are using at least 
one CAM treatment currently was considered as CAM 
users and participants who are not using any CAM 
treatment currently were classified as non-CAM users. 
One-way ANOVA was conducted on different outcomes 
with two CAM use groups. Three satisfaction groups 
were created in order to explore how satisfaction with 
current CAM use impact on negative life impact and fre-
quency of migraine; (1) Satisfied Group, which includes 
participants answering either highly satisfied or satisfied 
with their current CAM treatment, (2) Neutral Group, 
which includes participants reporting neutral satisfac-
tion with current CAM treatment, and (3) CAM Dissat-
isfaction Group, which includes participants responding 
either highly dissatisfied or dissatisfied with their current 
CAM treatment. One-way ANOVAs were performed on 
different outcomes with three CAM Satisfaction Groups.
Results
The characteristics of CAM users versus non‑CAM users
Figure 1 shows that CAM users are more likely to expe-
rience prolonged or frequent migraine headaches spe-
cifically lasting longer than 4 h for more than 20 days per 
month, have more years of suffering from migraine head-
aches, are more likely to visit headache specialist, and 
experience more negative life impact, and tend to experi-
ence depression and anxiety.
One-way ANOVA tests were performed to deter-
mine statistical differences in migraine frequency, 
migraine years, and negative life impact between CAM 
users and non-CAM users. As shown in Table  4, there 
was a significant effect of CAM status on negative life 
impact (p =  .000, η2 =  .0172), years since first migraine 
(p  =  .018, η2  =  .0021), migraine frequency (p  =  .001, 
η2  =  .0038), number of migraine symptoms (p  =  .000, 
η2  =  .1253), number of psychiatric comorbid disorders 
(p = .000, η2 = .0266) and triggers to migraine (p = .000, 
η2  =  .0555). These results indicated that CAM users 
experienced significantly more negative life impact, suf-
fered from migraine lasting more than 4  h for more 
days per month and for more years, experienced more 
Table 3 ANOVA of  migraine factors comparing groups 
on CAM use status
F(df‑btw, df‑tot) p η2
Negative life impact 47.382 (1, 2709) .000 .0172
Years since first migraine 5.585 (1, 2709) .018 .0021
Frequency of migraine symptoms 
lasting 4+
10.290 (1, 2709) .001 .0038
Number of migraine symptoms 388.026 (1, 2709) .000 .1253
Number of psychiatric comorbid 
disorders
74.105(1, 2709) .000 .0266
Triggers to migraine 1361.729 (1, 2709) .000 .0555 Fig. 1 Comparisons of responses (in percent) by CAM use status 
(N = 2710)
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migraine symptoms and more psychiatric comorbidities, 
and identified more triggers to migraine compared to 
non-CAM users.
The prevalence of patterns of CAM use
The prevalence and patterns CAM use were summarized 
in the Table 4. Each participant was instructed to select 
CAM treatment that they were currently using and was 
also allowed to select more than one CAM treatment. 
According to the Table 4, avoiding light, hot/cold therapy, 
diet, taking vitamin supplements, acupuncture, chiro-
practic, and relaxation/meditation were the frequently 
used CAM treatment among the participants of the pre-
sent study. Almost half of the participants reported that 
they are currently using more than three different CAM 
treatments even though the majority of the participants 
reported neutral or dissatisfied with their current CAM 
treatment (Table 4).
The details of negative life impact affected by migraine 
headache
As shown in Table  5, nearly half of the participants 
responded that migraine headache affected various aspect 
of their life such as their professional advancement, their 
interpersonal relationships, and their marriage.
The relationship between satisfaction with current CAM 
use and quality of life and migraine headache
One-way ANOVA tests were performed to see whether 
there were significant differences in negative life impact 
and frequency of migraine headache among three CAM 
satisfaction status groups. Results indicated that there 
were significant differences in negative life impact 
(p  =  .000, η2  =  .0287), frequency of migraine lasting 
more than 4 h per month (p = .000, η2 = .0550), number 
Table 4 Type and  numbers of  current CAM use and  CAM 
use satisfaction (N = 2477)




















































Current CAM use (number of methods used)
 0 356 (13.1)
 1 429 (15.8)
 2 632 (23.3)
 3 557 (20.6)
 4 or more 736 (27.2)
Current CAM use satisfaction
 Strongly dissatisfied and dissatisfied 861 (31.7)
 Neutral 991 (36.6)
 Strongly satisfied and satisfied 625 (23)
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of migraine symptoms (p = .000, η2 = .0149) and number 
of psychiatric comorbid disorders (p = .003, η2 = .0048) 
among three groups (shown in Table 6).
In order to further examine group differences, Scheffe 
post hoc tests were performed. Post-hoc test results 
revealed that CAM Dissatisfaction Group experienced 
significantly more negative life impact compared to CAM 
Neutral Group and CAM Satisfaction Group whereas 
CAM Neutral Group experienced significantly more nega-
tive life impact than CAM Satisfaction Group (Fig.  2). 
Similar patterns were observed for migraine headache fre-
quency. As shown in Fig.  2, CAM Dissatisfaction Group 
experienced significantly more frequent migraine head-
ache compared to CAM Neutral Group and CAM Satis-
faction Group. There were significant difference between 
CAM Neutral Group and CAM Satisfaction Group indi-
cating that CAM Neutral Group experience more frequent 
migraine headaches than CAM Satisfaction Group (Fig. 2).
Number of migraine symptoms and psychiatric comor-
bid disorders revealed similar patterns; CAM Dissatis-
faction Group experienced significantly more migraine 
symptoms and psychiatric comorbidities compared 
to CAM Neutral Group and CAM Satisfaction Group 
whereas there were no significant differences between 
CAM Neutral Group and CAM Satisfaction Group 
(Fig. 2). Lastly, as shown in Fig. 2, different pattern was 
observed on triggers to migraine; CAM Satisfaction 
Groups identified significantly more triggers than CAM 
Neutral Group and CAM Dissatisfaction Group whereas 
no significant difference was observed between CAM 
Neutral Group and CAM Dissatisfaction Group.
Path analysis of treatment satisfaction (CAM treatment) 
on negative life impact of migraine
Figure  3 showed the differential relationships among 
treatment satisfaction of CAM use, migraine outcomes, 
psychiatric comorbid disorders, and negative life impact. 
CAM treatment satisfaction was significantly negatively 
related to number of psychiatric comorbidities, frequency 
of migraine, and number of migraine symptoms. CAM 
treatment satisfaction was more strongly correlated with 
migraine outcomes (e.g., frequency and migraine symp-
toms) compared to psychiatric comorbidities. However, 
migraine outcomes and psychiatric comorbidities were 
all significantly positively related to negative life impact.
Discussion
Consistent with previous studies (Adams et al. 2013; Gaul 
et al. 2009; Lambert et al. 2010; Malone et al. 2015; Rossi 
et  al. 2006; Wachholtz et  al. 2015), the present study 
revealed that CAM users were more likely to have comor-
bid mental health issues, suffered from more intense 
headaches for a longer period of time, and experienced 
more negative life impact of migraine compared to Non-
CAM users. These results suggest that individuals may 
seek out alternative sources of healing when standard 
biomedical treatments do not meet their needs, are too 
expensive, considered too dangerous, or the side effects 
of treatments are too overwhelming. In spite of common 
use of CAM treatments as the last resort to treat intense 
intractable pain, migraineurs usually do not inform their 
medical providers about their CAM use (Lambert et  al. 
2010; Rossi et al. 2006). This result highlights the impor-
tance of investigating the patterns of CAM use among 
chronic migraineurs. A number of studies (Adams et al. 
2013; Gaul et  al. 2009; Lambert et  al. 2010; Rossi et  al. 
2006) examined migraineurs’ CAM using patterns but 
most studies were conducted in headache clinics so the 
present study investigated the CAM use among chronic 
migraineurs in the community settings.
According to the current study, managing triggers 
such as avoiding light and applying hot and cold packs 
were the most commonly used CAM treatment among 
chronic migraineurs. Next frequently used CAM treat-
ments include nutritional therapies. These results can be 
explained by people’s tendency to select the CAM meth-
ods that are most easily available when treating migraine 
symptoms and trying CAM for the first time. More 
extensive therapies such as massage, acupuncture and 
chiropractic treatment were also frequently used CAM 
treatments among the participants of the current study 
but were less popular than home-based CAM options, 
Table 5 Negative life impact of  migraine headaches 
(N = 2710)
Event N (%)
Migraine affect my ability to maintain relationships 1027 (37.9 %)
Migraines have impacted professional advancement 1207 (44.5 %)
I have lost a job due to my migraine 612 (22.6 %)
Migraines impact my relationship with my child/children 476 (17.6 %)
I’ve lost friends due to my migraines 183 (6.8 %)
Migraines contributed to my divorce/separation 1029 (38 %)
Table 6 One-way ANOVA in negative life impact, migraine 
outcomes, and  psychiatric comorbid disorders by  current 
CAM Satisfaction Groups
F(df‑btw, df‑tot) p η2
Negative life impact 36.564 (2, 2476) .000 .0287
Frequency of migraine symptoms 
lasting 4+
71.965 (2, 2476) .000 .0550
Number of migraine symptoms 18.643 (2, 2476) .000 .0149
Number of psychiatric comorbid 
disorders
5.916 (2, 2476) .003 .0048
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which were consistent with the results from previous 
studies (Gaul et al. 2009; Rossi et al. 2006). These results 
may suggest important clinical implications for chronic 
migraineurs. Individuals with chronic migraine may 
experience difficulty in engaging in more extensive CAM 
treatments on a consistent basis due to their physical 
disability associated with migraine and economic costs 
related to these non-home based CAM practices. How-
ever, they may be more willing to try methods they can 
practice at home such as managing triggers, monitoring 
Fig. 2 Scheffe test: three satisfaction groups on outcomes. Note: Arrow signs indicate statistically significant different between two satisfaction 
groups
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their pain and symptoms, and self-pain-management 
techniques such as meditation/relaxation and activi-
ties that enhance mental well-being (e.g., pet therapy, 
music, prayer). According to the current study, almost 
half of the chronic migraineurs identified various triggers 
to their migraine headaches; however, only 35  % of the 
participants reported keeping a journal to track migraine 
episodes. Education for tracking migraine episodes will 
enhance chronic migraineurs’ ability in managing trig-
gers to migraine. Two of the most frequently identi-
fied triggers to migraine among chronic migraineurs in 
the present study were stress and lack of sleep. Those 
two factors can contribute to the development of other 
comorbid disorders such as psychological problems and 
sleep disorders when those become chronic, therefore, it 
should be important for health care providers to provide 
sleep hygiene education and make a referral to psycho-
therapy interventions such as sleep education or stress 
management therapy when treating chronic migraineurs.
Like most chronic illnesses, migraine headaches pro-
foundly impact individuals’ health as well as his/her fam-
ily and vocational life. Previous research suggested the 
impacts of migraine headache on different aspects of life 
(Lipton et al. 2003; Malone et al. 2015; Smitherman et al. 
2011; Wachholtz et  al. 2015) and the impact of migraine 
in physical and social functioning was even greater for 
migraineurs compared to individuals who struggle with 
other chronic illnesses (Solomon et al. 1994). The present 
study revealed that chronic migraine headaches placed 
similar burden on migraineurs to non-chronic migraineurs 
as chronic migraine not only causes physical disability but 
also brings social disability due to its chronicity and breath 
of symptoms associated with migraine. Thus, a multi-dis-
cipline approach in treatment planning can be beneficial 
in assisting chronic migraineurs. In addition to traditional 
pharmacological treatments, various CAM treatments 
such as psychosocial treatments, nutritional treatments, 
and bodywork therapies can be recommended to chronic 
migraineurs in order to manage their migraine symptoms.
It should also be noted that migraines may be treat-
ment resistant. The majority of the participants in the 
present study reported that they suffered from migraine 
headaches for more than 10  years and either avoided 
or stopped migraine medications due to side effects. 
Furthermore, high numbers of chronic migraineurs in 
the current study reported either neutral or dissatisfac-
tion with either pharmacological treatments or CAM 
treatments, which was consistent with previous stud-
ies (Malone et  al. 2015; Wachholtz et  al. 2015). In spite 
of its limited benefit, chronic migraineurs are known 
to attempt multiple CAM treatments and this treat-
ment-seeking-pattern may occur because (1) traditional 
Fig. 3 Path analysis of CAM treatment on negative life impact
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pharmacological treatments do not properly address 
their pain and symptoms associated with migraine; and 
(2) CAM treatments help chronic migraineurs to reduce 
negative impact of migraine by improving their physical 
and mental wellbeing.
Examining the negative effects of migraine in different 
domains of life is well established in previous research, 
however, a closer look at the relationship between treat-
ment satisfaction with CAM use and negative life impact 
by investigating factors affecting both treatment satisfac-
tion with CAM use and negative life impact has not been 
conducted in previous studies. According to the present 
study, when migraineurs had greater satisfaction with 
alternative medicine treatment, they concurrently had 
lower levels of negative life impact, less frequently suffered 
from prolonged migraine headaches, experienced less 
symptoms associated with migraine, and were less likely to 
experience psychiatric comorbidities. We would postulate 
that these results occur because “satisfaction” means that 
migraineurs have experienced some symptom relief with 
their CAM treatment, where as “dissastified” suggests that 
they have not experienced relief from CAM treatments, 
so they are still suffering and may not see an end to their 
headaches leading to greater psychiatric comorbidities.
Therefore, satisfaction with CAM treatments may play 
protective factor for negative effects of migraine head-
ache in daily functioning.
In order to further explore the relationship between 
CAM treatment satisfaction and negative life impact, 
the present study examined migraine outcomes (e.g., 
migraine frequency and number of migraine symptoms) 
and psychiatric comorbidity (e.g., anxiety, depression, 
bipolar disorder, PTSD etc.) and how those factors are 
associated with CAM treatment satisfaction and nega-
tive life impact. The results of the present study showed 
that the inverse relationship between CAM treatment 
satisfaction and psychiatric comorbidities was weaker 
than the inverse relationship between CAM treatment 
satisfaction and migraine outcomes although psychiatric 
comorbidities and migraine outcomes were all strongly 
associated with greater levels of negative life impact. 
These results may indicate that CAM treatment may 
affect mental well-being of chronic migraineurs posi-
tively but in a lesser degree compared to the degree that 
the effectiveness of CAM treatments affects migraine 
outcomes. One partial explanation for this is that rela-
tively few numbers of CAM treatments identified in 
the present study were devoted to improving mental 
health well-being. In the present study, psychiatric and 
psychological factors may play the important roles as a 
contributing factor (i.e., stress as one of the most fre-
quently identified triggers to migraine) as well as a pre-
cipitating factor (i.e., psychiatric comorbidities were 
the most common comorbid disorders among chronic 
migraineurs) to migraine headache. Psychiatric comor-
bidities may also be a risk factor to negative life expe-
riences. For instance, chronic migraineurs may blame 
migraine headache for their disabilities when their dis-
abilities are actually due to their psychiatric comor-
bidities (Wachholtz et al. 2015) or their pain experience 
caused by migraine may have been amplified due to 
psychiatric comorbidities. These results are significant 
because they emphasized the importance of treating 
psychiatric comorbidities in chronic migraineurs since 
appropriate care of the psychiatric comorbidities can 
directly affect quality of life and/or indirectly to increase 
quality of life by reducing migraine symptoms. Previous 
study (Pistoia et al. 2013) indicated that combined treat-
ments to target both migraine symptoms and psycho-
logical co-morbidities in order to enhance the quality 
of life for chronic migraineurs are important, however, 
only few studies (Kleiboer et  al. 2014) investigated the 
effectiveness of psychological treatments on chronic 
migraineurs.
Limitations
Despite the contributions of the present study to the 
field, there are some limitations. Although the present 
study recruited participants from one major US migraine 
headache website and have similar demographics to US 
migraineurs, the participants of the present study may 
not be representative for all migraineurs as it was self-
selected sample, which is the standard method of collect-
ing data in on-line survey study. In addition, the present 
study measured symptoms associated with migraine as 
well as the negative life impact caused by migraine head-
aches. Future studies need to include questionnaires as 
well as qualitative methods such as individual interviews 
as well as focus group data in order to provide more 
detailed pictures of the negative impact of migraine head-
ache as well as the experiences of chronic migraineurs 
who seek self-care resources on-line.
Conclusions
The present study contributed to the field by increasing 
our knowledge about migraine characteristics, CAM use 
patterns, and the differential relationships among CAM 
treatment satisfaction, migraine headache outcomes, psychi-
atric comorbidities, and negative life impact among chronic 
migraineurs. Chronic migraineurs usually pursue multiple 
CAM treatments in spite of low levels of satisfaction with 
their treatments as they tend to suffer from more severe 
symptoms of migraine and more psychiatric comorbidities 
without significant improvement from traditional medi-
cal treatments. Consistent with previous literature, chronic 
migraineurs experience a broad range of migraine symptoms 
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and those symptoms negatively affect various aspects of 
chronic migraineurs’ life. This shows the complex nature of 
migraine headache compared to other chronic illnesses and 
therefore calls for multidisciplinary approach to treatment. 
CAM treatment may play a protective factor against nega-
tive life experiences among chronic migraineurs. However, 
CAM treatments may have a limited benefit for psychiatric 
comorbidities. More attention is needed to consider psychi-
atric and psychological factors in planning the treatment of 
chronic migraineurs as those factors may play an important 
role in disease process of migraine headache. The implemen-
tation of psychosocial interventions for chronic migraineurs, 
the proper referral system to psychiatric and psychological 
treatments by treatment providers, and the establishment of 
clinical guidelines for evidence-based CAM treatments that 
target mental well-being in the context of headache clinics 
can enhance the quality of life among chronic migraineurs. 
In order to develop clinical guidelines of CAM treatments 
that focus on mental wellbeing as well as psychiatric and 
psychological treatments, future studies should examine lon-
gitudinal changes based on different types of CAM use that 
target mental well-beings.
Authors’ contributions
JL participated in the development of main concepts for the present manu-
script, performed the statistical analysis and the interpretation of the data, 
and wrote the manuscript. AW participated in the design of the present study, 
acquired the data, provided guidance and feedback in data analysis and data 
interpretation, and helped to draft the manuscript. AB participated in the 
study design and coordination of data collection, and helped to draft the 
manuscript. All authors read and approved the final manuscript.
Author details
1 Psychology Department, Chung-Ang University, 84 Heukseok-ro, Dong-
jak-gu, Seoul, Korea. 2 VP Community Development, Health Union LLC, 1 
International Plaza, Philadelphia, PA 19113, USA. 3 Department of Psychology, 
University of Colorado Denver, Denver, CO 80204, USA. 
Acknowledgements
Research reported in this publication was supported by the National Institute 
on Drug Abuse of the National Institutes of Health under Award Number 
K23DA030397 to Amy Wachholtz. The content is solely the responsibility 
of the authors and does not necessarily represent the official views of the 
National Institutes of Health.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
All methods were approved by the University of Massachusetts IRB and all par-
ticipants indicated their consent to participate in the study prior to answering 
any of the study questions.
Received: 14 April 2016   Accepted: 18 May 2016
References
Adams J, Barbery G, Lui CW (2013) Complementary and alternative medicine 
use for headache and migraine: a critical review of the literature. J Head 
Face Pain 53(3):459–473
Burch R, Lode S, Lode E, Smitherman T (2015) The prevalence and burden of 
migraine and severe headache in the United States: updated statis-
tics from government health surveillance studies. J Head Face Pain 
55(1):21–34
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kes-
sler RC (1998) Trends in alternative medicine use in the United States, 
1990–1997: results of a follow-up national survey. JAMA 280:1569–1575
Gaul C, Eismann R, Schmidt T, Ma A, Leinisch E, Wiesse T, Ever S, Henkel K, 
Franz G, Zierz S (2009) Use of complementary and alternative medicine 
in patients suffering from primary headache disorders. Cephalalgia 
29:1069–1078
Jacobson IG, White MR, Smith TC, Smith B, Wells TS, Gackstetter GD (2009) 
Self-reported health symptoms and conditions among complementary 
and alternative medicine users in a large military cohort. Annu Epidemiol 
19(9):613–622
Kaptchuck TJ, Eisenberg DM (1998) The persuasive appeal of alternative medi-
cine. Ann Intern Med 129:1061–1065
Kleiboer A, Sorbi M, Silfhout M, Kooistra L, Passchier J (2014) Short-term effec-
tiveness of an online behavioral training in migraine self-management: a 
randomized controlled trial. Behav Res Therapy 61:61–89
Lambert TD, Morrison KE, Edwards J, Clarke CE (2010) The use of complemen-
tary and alternative medicine by patients attending a UK headache clinic. 
Complement Ther Med 18:128–134
Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) 
Migraine headache disability and health-related quality of life: a popula-
tion-based case control study from England. Cephalagia 23:441–450
Malone CD, Bhowmick A, Wachholtz AB (2015) Migraine: treatments, comor-
bidities, and quality of life, in the USA. J Pain Res 5(8):537–547
Pistoia F, Sacco S, Carolei A (2013) behavioral therapy for chronic migraine. 
Curr Pain Headache Rep 17:303–311
Rossi P, Lorenzo GD, Malpezzi MG, Faroni J, Cesarino F, Lorenzo CD, Nappi G 
(2005) Prevalence, pattern and predictors of use of complementary and 
alternative medicine (CAM) in migraine patients attending a headache 
clinic in Italy. Cephalagia 25:493–506
Rossi P, Lorenzo GD, Malpezzi MG, Faroni J, Malpezzi MG, Cesarino F, Nappi 
G (2006) Use of complementary and alternative medicine by patients 
with chronic tension-type headache: results of a headache clinic survey. 
Headache 46:622–631
Smitherman TA, McDermott MJ, Buchanan EM (2011) Negative impact of 
episodic migraine on a university population: quality of life, functional 
impairment, and comorbid psychiatric symptoms. Headache 51:581–589
Solomon GD, Skobieranda FG, Gragg LA (1994) Does quality of life differ 
among headache diagnoses? Analysis using the medical outcomes study 
instrument. Headache 34:143–147
Wachholtz A, Malone C, Bhowmick A (2015) The chronic migraineur and 
health services: national survey results. Pain Manag Med 1(1):1–7
Wells RE, Bertisch SM, Buettne C, Phillip RS, McCarthy EP (2011) Complemen-
tary and alternative medicine use among adults with migraines/severe 
headaches. Headache 51(7):1087–1097
Zollman C, Vickers A (1999) ABC of complementary medicine: what is 
complementary medicine? Br Med J 319(7211):693–696. doi:10.1136/
bmj.319.721111.69
